Recent CF Publications

Aug 12, 2026

Utilization of Des-Gamma-Carboxy-Prothrombin in Estimating Vitamin K Status in People With Cystic Fibrosis: A Single Center Retrospective Review

https://doi.org/10.1002/ppul.71777

Aug 4, 2026

Shifting Nutrition Paradigms: Changing Attitudes Towards Diet and Body Perceptions Among People With CF in the Era of Highly Effective Modulators

https://doi.org/10.1111/jhn.70323

Jul 27, 2026

EASE-CF: dietitian-led weight-loss intervention for adults with cystic fibrosis and excess weight: protocol for a feasibility randomised controlled trial

https://doi.org/10.1136/bmjresp-2026-004328

Jul 1, 2026

Cystic fibrosis nutrition: Addressing emerging trends following the 2024 ESPEN-ESPGHAN-ECFS guidelines. Expert opinion recommendations

https://doi.org/10.1016/j.jcf.2026.06.010

Jun 26, 2026

Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care

https://onlinelibrary.wiley.com/doi/10.1002/ppul.71177

Jun 25, 2026

Diet composition and quality in children with cystic fibrosis in the modulator era: A scoping review

https://doi.org/10.1016/j.clnu.2026.106718

May 19, 2026

Cystic fibrosis related diabetes - viewpoints on three research areas presented at the 20th ECFS basic science conference

https://doi.org/10.1016/j.jcf.2026.05.008

May 13, 2026

Evolution of body image across treatment eras: a systematic review in young people and adults living with cystic fibrosis

https://doi.org/10.1183/16000617.0238-2025

May 5, 2026

Utility of Fecal Elastase-1 in Estimating Exocrine Pancreatic Function in Cystic Fibrosis: A Scoping Review

https://doi.org/10.1002/ppul.71649

Apr 28, 2026

Evaluation of Family History of Diabetes and the Development of CFRD in a Clinical Cystic Fibrosis Cohort

https://doi.org/10.1016/j.eprac.2026.04.013

Apr 3, 2026

The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat-Soluble Vitamin Status and Supplementation in a Pediatric Cystic Fibrosis Cohort

https://doi.org/10.1002/ppul.71596

Mar 31, 2026

Changes in nutritional priorities and management in people with CF

https://doi.org/10.1016/j.jcf.2026.03.026

Feb 16, 2026

Consensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR/TEZACAFTOR/IVACAFTOR

https://doi.org/10.1016/j.jcf.2026.02.004

Jan 15, 2026

Interrelationships among handgrip strength, body composition, physical activity, and quality of life in adults with cystic fibrosis: A cross-sectional study

https://doi.org/10.1002/ncp.70087

Dec 19, 2025

Remotely addressing health-related social needs (ELICIT) in cystic fibrosis: design and implementation of a multicenter screening and intervention quality improvement project

https://doi.org/10.1177/17534666251393088

Nov 4, 2025

Persistent plasma and RBC fatty acid abnormalities in children and adolescents with cystic fibrosis on highly effective CFTR modulators

https://doi.org/10.1016/j.jcf.2025.10.011

Aug 27, 2025

Review of Disordered Eating Behaviors in Cystic Fibrosis

https://doi.org/10.3390/life15091355

Jun 18, 2025

Evolving nutrition therapy in cystic fibrosis: Adapting to the CFTR modulator era

https://doi.org/10.1002/ncp.11332

Jun 17, 2025

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase-1 in Children With Cystic Fibrosis

https://onlinelibrary.wiley.com/doi/10.1002/ppul.71156

Jun 6, 2025

Relationship between skeletal muscle indicators and clinical outcomes in cystic fibrosis is modified by adiposity and CFTR modulator use: A cross-sectional analysis

https://doi.org/10.1016/j.ajcnut.2025.09.019